Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: time-to-event returned 29 record(s)
|
|
Monday, 07/31/2017
|
Event Rate Estimation Based on Blinded Time-To-Event Data to Verify Sample Size Calculation Assumptions
Youlan Rao, United Therapeutics Corporation, Durham, NC; Suhyun Kang, North Carolina State University, Raleigh, NC; Jody Cleveland, United Therapeutics Corporation, Durham, NC; Chunqin Deng, United Therapeutics Corporation, Durham, NC
|
How We Take Advantage of Big Data When Dealing with the Dilemma in Early-Phase Oncology?
Shaoyi Li, Celgene
|
Time-to-event analysis when the event of interest is defined on a finite time interval and is subject to a competing risk
Catherine Lee; Sebastien Haneuse, TE-Harvard T.H. Chan School of Public Health
|
Bayesian Adjustment for Confounding When Estimating Average Causal Effects for Time-To-Event Outcomes
Li Xu; Arnold Stromberg, Department of Statistics, University of Kentucky; Chi Wang, Cancer Biostatistics, University of Kentucky
|
A Simulation Based Clinical Trial Design for Time-To-Event Endpoint Using the Concept of Relative Time Utilizing the Generalized Integer Gamma Distribution
Milind Phadnis
8:50 AM
|
Bayesian Adjustment for Confounding When Estimating Average Causal Effects for Time-To-Event Outcomes
Li Xu; Arnold Stromberg, Department of Statistics, University of Kentucky; Chi Wang, Cancer Biostatistics, University of Kentucky
9:00 AM
|
Modeling and Estimation of Contagion-Based Social Network Dependence with Time-To-Event Data
Lin Yu, North Carolina State University; Wenbin Lu, North Carolina State University
10:50 AM
|
Testing and Estimation of Social Network Dependence with Time-To-Event Data
Lin Su, North Carolina State University; Wenbin Lu, North Carolina State University; Rui Song, NC State University; Danyang Huang, Renmin University
11:20 AM
|
On Effect Sizes for Nonparametric Comparison of Censored Survival Outcomes
Yongzhao Shao, New York University-School of Medicine; Zhaoyin Zhu, NYU
11:50 AM
|
Time-to-event analysis when the event of interest is defined on a finite time interval and is subject to a competing risk
Catherine Lee; Sebastien Haneuse, TE-Harvard T.H. Chan School of Public Health
11:55 AM
|
Designing Multi-Stage Clinical Trials with Multiple Event-Time Endpoints
Toshimitsu Hamasaki, National Cerebral and Cardiovascular Center; Scott Evans, Harvard University ; Tomoyuki Sugimoto, Kagoshima University; Koko Asakura, National Cerebral and Cardiovascular Center
2:45 PM
|
Confirmatory Group Sequential Adaptive Designs for Time-To-Event Endpoints Using a Short-Term Endpoint for Treatment Arm or Population Selection
Gernot Wassmer, Medical University of Vienna, Austria; Martin Posch, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University o; Franz Koenig, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University o; Silke Joergens, ICON Clinical Research Inc, Cologne Germany
3:05 PM
|
|
Tuesday, 08/01/2017
|
Bivariate Copula Modeling of Genetic Effects on AMD Progression with Intermittent Assessment Times
Tao Sun, University of Pittsburgh; Yi Liu; Wei Chen, University of Pittsburgh; Ying Ding, University of Pittsburgh
|
Immortal Time Bias in Observational Studies of Time-To-Event Outcomes: Assessing Effects of Post-Mastectomy Radiation Therapy Using National Cancer DataBase (NCDB) Study
Parul Agarwal, Icahn School of Medicine at Mount Sinai; Erin Moshier, Icahn School of Medicine at Mount Sinai; Meng Ru, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai
|
Propensity Score Methods for Analysis Time-To-Event Data
Haiying Lin
|
Numerical Evaluation of the Efficiency of a Binary Versus Time-To-Event Endpoint
Zhibao Mi, VA CSPCC Perry Point; Eileen Stock, VA CSPCC Perry Point; Kousick Biswas, VA Cooperative Studies Program Coordinating Center; Joseph F Collins, VA Cooperative Studies Program Coordinating Center
|
Immortal Time Bias in Observational Studies of Time-To-Event Outcomes: Assessing Effects of Post-Mastectomy Radiation Therapy Using National Cancer DataBase (NCDB) Study
Parul Agarwal, Icahn School of Medicine at Mount Sinai; Erin Moshier, Icahn School of Medicine at Mount Sinai; Meng Ru, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai
8:40 AM
|
A Two-Stage Design for Phase III Trials with Population Selection
Wen Li, Merck & Co. Inc.
8:50 AM
|
Numerical Evaluation of the Efficiency of a Binary Versus Time-To-Event Endpoint
Zhibao Mi, VA CSPCC Perry Point; Eileen Stock, VA CSPCC Perry Point; Kousick Biswas, VA Cooperative Studies Program Coordinating Center; Joseph F Collins, VA Cooperative Studies Program Coordinating Center
9:05 AM
|
Dynamic Predictions in Bayesian Functional Joint Models for Longitudinal and Time-To-Event Data: An Application to Alzheimer's Disease
Kan Li, The University of Texas Health Science Center at Houston ; Sheng Luo, The University of Texas Health Science Center at Houston
9:50 AM
|
A Joint Model Approach for Longitudinal Data with No Time Zero and Time-To-Event with a Competing Risk
Sung Duk Kim, National Cancer Institute/NIH; Olive Buhule, NICHD/NIH; Paul S. Albert, National Cancer Institute/NIH
9:50 AM
|
Flexible Bayesian Additive Joint Models
Meike Köhler, Helmholtz Zentrum München; Nikolaus Umlauf, Universität Innsbruck; Sonja Greven, Ludwig-Maximilians-Universität München
11:00 AM
|
Propensity Score Methods for Analysis Time-To-Event Data
Haiying Lin
11:00 AM
|
A Versatile Test Based on Restricted Mean Survival Time for Time-To-Event Outcomes
Miki Horiguchi, Kitasato University; Hajime Uno, Dana Farber Cancer Institute
2:20 PM
|
Adapting the 5-Zone Adaptive Design
Yi Liu, Takeda; Mingxiu Hu, Takeda Pharmaceutical
3:05 PM
|
|
|
